MFS
CHRS icon

MSI Financial Services’s Coherus Oncology CHRS Stock Holding History

MSI Financial Services’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5K Hold
160
– – ﹤0.01% 3129
2016
Q3 		$4K Buy
+160
New +$4.37K ﹤0.01% 3219

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MSI Financial Services's CHRS Position: Q4 2016 in Review

MSI Financial Services held its Coherus Oncology (CHRS) position steady in Q4 2016 at 160 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #3129.

MSI Financial Services first reported a position in CHRS in Q3 2016 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold CHRS as of Q4 2016.

  • MSI Financial Services held 160 shares of Coherus Oncology worth $5K as of Q4 2016.
  • MSI Financial Services left its Coherus Oncology share count unchanged in Q4 2016.
  • Coherus Oncology made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3129 holding.
  • MSI Financial Services first reported a position in Coherus Oncology in Q3 2016 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.